Literature DB >> 8000975

Autosomal recessive, fatal infantile hypertonic muscular dystrophy among Canadian Natives.

A G Lacson1, S S Seshia, H B Sarnat, J Anderson, W R DeGroot, A Chudley, C Adams, H Z Darwish, R B Lowry, S Kuhn.   

Abstract

We describe eleven mid-western Canadian aboriginal infants with a unique, progressive muscle disorder. All except one had muscle biopsy and/or autopsy. The infants were normal newborns who rapidly developed rigidity of all skeletal muscles, with early, respiratory insufficiency. Death occurred before 18 months of age. Electromyography showed increased insertion activity and profuse fibrillation potentials; motor unit potentials and interference pattern are normal until late in the course. Pathologic features include progressive, granular to powdery Z-band transformation, myofibrillar loss, and muscle regeneration. SDS-gel electrophoresis of one muscle sample revealed increased 54kDa and reduced 80kDa protein fractions. This disease differs from other conditions with Z-band alterations because of continuous muscle activity and relentless clinical progression. The clinical features, elevated serum creatine kinase, electromyographic and muscle biopsy findings suggest a dystrophic process. The recognition of this condition as an autosomal recessive disorder allows appropriate genetic counselling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000975     DOI: 10.1017/s0317167100041172

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  3 in total

Review 1.  The BAG3-dependent and -independent roles of cardiac small heat shock proteins.

Authors:  Xi Fang; Julius Bogomolovas; Christa Trexler; Ju Chen
Journal:  JCI Insight       Date:  2019-02-21

2.  Infantile muscular dystrophy in Canadian aboriginals is an αB-crystallinopathy.

Authors:  Marc R Del Bigio; Albert E Chudley; Harvey B Sarnat; Craig Campbell; Sharan Goobie; Bernard N Chodirker; Duygu Selcen
Journal:  Ann Neurol       Date:  2011-02-18       Impact factor: 10.422

3.  Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.

Authors:  Duygu Selcen; Mark B Bromberg; Steven S Chin; Andrew G Engel
Journal:  Neurology       Date:  2011-11-16       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.